Cleared Traditional

K003977 - DISETRONIC RAPID SUBCUTANEOUS INFUSION SET AND DISTERONIC RAPID D SUBCUTANEOUS INFUSION SET

K003977 is an FDA 510(k) clearance for DISETRONIC RAPID SUBCUTANEOUS INFUSION ..., manufactured by Disetronic Medical Systems AG. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 55-day FDA review.

K003977 · Disetronic Medical Systems AG · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2001
Decision
55d
Days
Class 2
Risk

K003977 is an FDA 510(k) clearance for the DISETRONIC RAPID SUBCUTANEOUS INFUSION SET AND DISTERONIC RAPID D SUBCUTANEOU.... Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Disetronic Medical Systems AG (St. Paul, US). The FDA issued a Cleared decision on February 15, 2001 after a review of 55 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Disetronic Medical Systems AG devices

FDA 510(k) Submission Details - K003977

510(k) Number K003977 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 22, 2000
Decision Date February 15, 2001
Days to Decision 55 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
74d faster than avg
Panel avg: 129d · This submission: 55d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 650
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K003977.
SURSHIELD WINGED INFUSION SET
K010103 · Terumo Medical Corp. · Mar 2001
SIMPLICITY SOFT Y INFUSION SET FOR USE WITH THE MINIMED INFUSION PUMPS AND MINIMED MEDICATION RESERVOIRS (MODEL MMT-103)
K010373 · Sterling Medivations, Inc. · Mar 2001
SWABSITE SWABBABLE VALVE, MODEL 245000
K002689 · Quest Medical, Inc. · Mar 2001
TAXOL ADMINISTRATION SET
K003513 · Icu Medical, Inc. · Jan 2001
SIMPLICITY WITH WINGS INFUSION SET, (MODEL MMT-103)
K003283 · Sterling Medivations, Inc. · Dec 2000
SIMPLICITY SOFT INFUSION SET
K002492 · Sterling Medivations, Inc. · Oct 2000